NCT05668364 is a NA clinical trial of Outdoor cold air exposure in Croup, sponsored by Pediatric Clinical Research Platform.

Who is sponsoring NCT05668364?

NCT05668364 is sponsored by Pediatric Clinical Research Platform.

What drugs are being tested in NCT05668364?

Interventions in NCT05668364: Outdoor cold air exposure.

Is NCT05668364 still recruiting?

NCT05668364 is currently completed. Last updated 11 January 2023.

Last reviewed 2023-01-11 · How we verify

NCT05668364

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Cold Air Exposure on Croup Symptoms

Completed NA Last updated 11 January 2023

What this trial tests

NA trial testing Outdoor cold air exposure in Croup in 118 participants. Completed in 31 May 2021.

Timeline

1 November 2016

Primary endpoint
31 May 2021

31 May 2021

Quick facts

Lead sponsor	Pediatric Clinical Research Platform
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	118
Start date	1 November 2016
Primary completion	31 May 2021
Estimated completion	31 May 2021

Drugs / interventions tested

Outdoor cold air exposure

Conditions studied

Croup — all drugs for Croup →

Sponsor

Pediatric Clinical Research Platform

Who can join

Adults 3 Months to 10, any sex, with Croup. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the present randomised controlled clinical trial is to compare the efficacy of a 30-minute exposition to cold, atmospheric, outdoor air on the severity of croup symptoms with exposition to indoor room air in children with mild to moderate croup receiving a single dose of dexamethasone during winter croup outbreaks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pediatric Clinical Research Platform trials

Trials by the same sponsor.

NCT04464603 — Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational Awareness · NA · not yet recruiting
NCT05557331 — Effectiveness of a Mobile App in Reducing Therapeutic TAT in an Emergency Department · NA · recruiting
NCT06373939 — Performance and Safety of the Pneumoscope Device in Adults and Children · NA · recruiting
NCT05318599 — Deep Learning Diagnostic and Risk-stratification for IPF and COPD · recruiting
NCT05764850 — Mechanisms of Type 1 Diabetes Endophenotypes · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05668364 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pediatric Clinical Research Platform
Last refreshed: 11 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing